Muhdo Health, a global leader in DNA and Epigenetic consumer testing, is thrilled to announce an exclusive distribution agreement with Rgentic Saglik Turizm ve Ticaret AS for genetic testing kits in Turkey.

To ensure a seamless customer experience, the Muhdo Health app will be translated into Turkish, allowing local consumers to easily view their results on their mobile devices. Additionally, Muhdo Health’s web-based Practitioner Portal will be available in Turkish, enabling local clinics to conduct consultations in the native language.

Rgentic will also introduce a dedicated Turkish-language Muhdo-branded website, https://muhdo.com.tr/, to support the partnership. This site will offer both DNA and Epigenetic tests to Turkish consumers and clinics.

This partnership represents a significant opportunity for the Muhdo brand to establish a strong presence in Turkey’s health and longevity sector.

Quotes from Leadership

Nathan Berkley, CEO of Muhdo Health, stated: “Increasing the exposure of the Muhdo brand in Turkey and partnering with a trusted entity with robust commercial connections will propel our business forward. This exclusive partnership enables Muhdo to reach a new audience in a territory renowned for health, wellbeing, and longevity.”

Tekin Aldemir, Director of Rgentic, commented: “As Rgentic, we are very excited to partner with Muhdo and provide our clients and partners with the best genetic and epigenetic testing solutions on the market. We also look forward to expanding this partnership in the near future beyond Turkey, leveraging our existing network in the neighbouring territories of Turkey.”

About Rgentic

Rgnetic is the leading agency for the mediation and care of medical services in the fields of Aesthetic and Plastic Surgery as well as Cosmetic Dentistry and Bariatric Surgery. It’s focus is on the highest medical standards, short waiting times and transparent and cost-effective pricing.

About Muhdo

Muhdo is the first company in the world to offer a true internal wellness epigenetic profiling program direct to companies and consumers, inspiring and supporting people to live healthier, happier, longer lives.  As a next generation genetic and big data company, it’s vision is the mass personalization of preventive and curative health through epigenetics and analytics, delivering a truly holistic and objective health and wellness program.

This press release was originally published on this site

You May Also Like

ValueZone Introduces Cutting-Edge Quantitative Trading for Increased Passive Income

The recent platform from ValueZone is designed to boost both profitability and…

DONKOLO: A Full DONKOLO Review of the Latest Blockchain and DeFi Innovations

DONKOLO is excited to announce the launch of its latest blockchain-based trading…

Vietnam’s PropTech Pioneer Meey Group Takes Bold Steps Toward International IPO

HANOI, Vietnam, Oct. 16, 2025 (GLOBE NEWSWIRE) — Meey Group, a pioneering force…

WEMIX Charts Strategic Path for Recovery and Global Growth

WEMIX, the blockchain-powered gaming platform by WEMADE, has announced a wide-ranging strategic…

New Online Casino Site Instant Casino Partners with Italian Serie A Team Juventus FC

Turin, Italy, 24th May 2024, Chainwire

Discover the DCK (DexCheck) Listing on XT.COM

XT.COM, the world’s first socially infused trading platform, is thrilled to announce…

Saros to Launch Revolutionary DLMM Technology on Solana

Saros, a leading decentralized finance protocol on Solana, today announced plans to…

Edge Of AI Podcast Launches with Industry-Leading Guests

The Edge Of Company is thrilled to announce the highly anticipated launch…

SmartDeFi™ Announces GENIUS Act-Compatible Token Launching Options

SmartDeFi™, the twice-audited next-generation token launchpad, today announced support for project creators…

VoltiCard Adoption On the Rise with a New Token Listing

Volt Inu, a decentralized finance (DeFi) platform, has recently integrated a new…